Are the best biotech and pharma stocks such as CSL, Neuren Pharmaceuticals, Fisher and Paykel and Telix Pharmaceuticals trading at bargain prices? Stocks in this sector have fallen between 30 per cent and 90 per cent. According to an article by Squire Servance published in Health Affairs, the Biotech Industry is at a tipping point for health equity investing. In this week's show Dale and Janine share their views on the best stock opportunities for Biotech and Pharma stocks and whether now is the right time to grab a bargain.